Retinal Vessel Diameter in Branch Retinal Vein Occlusion
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02215109|
Recruitment Status : Completed
First Posted : August 13, 2014
Last Update Posted : August 30, 2016
|Condition or disease|
|Branch Retinal Vein Occlusion|
|Study Type :||Observational|
|Actual Enrollment :||25 participants|
|Official Title:||Change of Retinal Vessel Diameter in Branch Retinal Vein Occlusion After Intravitreal Bevacizumab Injection|
|Study Start Date :||April 2012|
|Actual Primary Completion Date :||July 2016|
|Actual Study Completion Date :||August 2016|
BRVO, Retinal vessel diameter
The retinal vessel diameter was measured Branch Retinal Vein Occlusion patients after intravitreal bevacizumab injection.
- Unoccluded retinal vessel diameter of Branch Retinal Vein Occlusion [ Time Frame: 0, 1, 3, and 6 months ]To evaluate the change of unoccluded retinal vessel diameter in affected eye of Branch Retinal Vein Occlusion and unaffected fellow eye.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02215109
|Korea, Republic of|
|Dong Ho Park|
|Daegu, Kyungsangpookdo, Korea, Republic of, 700-721|
|Principal Investigator:||Dong Ho Park, M.D.||Kyungpook National University Hospital|